Title : Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.

Pub. Date : 2000 Jan-Feb

PMID : 10732318






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation. Metoclopramide prolactin Homo sapiens
2 OBJECTIVE: The gastrointestinal motility agents metoclopramide and domperidone are known to increase pituitary prolactin (PRL) secretion and breast milk production. Metoclopramide prolactin Homo sapiens
3 OBJECTIVE: The gastrointestinal motility agents metoclopramide and domperidone are known to increase pituitary prolactin (PRL) secretion and breast milk production. Metoclopramide prolactin Homo sapiens
4 Metoclopramide and domperidone both caused a significant increase in PRL. Metoclopramide prolactin Homo sapiens
5 Nulliparous women had the quickest and highest PRL secretion with metoclopramide 10 mg, compared with the PRL response with metoclopramide 5 mg and domperidone 10 mg. Conversely, multiparous women had PRL secretion patterns that were equivalent between the medications. Metoclopramide prolactin Homo sapiens
6 Nulliparous women had the quickest and highest PRL secretion with metoclopramide 10 mg, compared with the PRL response with metoclopramide 5 mg and domperidone 10 mg. Conversely, multiparous women had PRL secretion patterns that were equivalent between the medications. Metoclopramide prolactin Homo sapiens
7 Nulliparous women had the quickest and highest PRL secretion with metoclopramide 10 mg, compared with the PRL response with metoclopramide 5 mg and domperidone 10 mg. Conversely, multiparous women had PRL secretion patterns that were equivalent between the medications. Metoclopramide prolactin Homo sapiens